328 related articles for article (PubMed ID: 24550495)
1. Circulating giant macrophages as a potential biomarker of solid tumors.
Adams DL; Martin SS; Alpaugh RK; Charpentier M; Tsai S; Bergan RC; Ogden IM; Catalona W; Chumsri S; Tang CM; Cristofanilli M
Proc Natl Acad Sci U S A; 2014 Mar; 111(9):3514-9. PubMed ID: 24550495
[TBL] [Abstract][Full Text] [Related]
2. Prognostic values of cancer associated macrophage-like cells (CAML) enumeration in metastatic breast cancer.
Mu Z; Wang C; Ye Z; Rossi G; Sun C; Li L; Zhu Z; Yang H; Cristofanilli M
Breast Cancer Res Treat; 2017 Oct; 165(3):733-741. PubMed ID: 28687903
[TBL] [Abstract][Full Text] [Related]
3. Beta 2-Adrenergic Receptor in Circulating Cancer-Associated Cells Predicts for Increases in Stromal Macrophages in Circulation and Patient Survival in Metastatic Breast Cancer.
Gardner KP; Cristofanilli M; Chumsri S; Lapidus R; Tang CM; Raghavakaimal A; Adams DL
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806301
[TBL] [Abstract][Full Text] [Related]
4. Filtration and Analysis of Circulating Cancer Associated Cells from the Blood of Cancer Patients.
Tang CM; Zhu P; Li S; Makarova OV; Amstutz PT; Adams DL
Methods Mol Biol; 2017; 1572():511-524. PubMed ID: 28299708
[TBL] [Abstract][Full Text] [Related]
5. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
[TBL] [Abstract][Full Text] [Related]
6. Detection and Characterization of Circulating Tumor Associated Cells in Metastatic Breast Cancer.
Mu Z; Benali-Furet N; Uzan G; Znaty A; Ye Z; Paolillo C; Wang C; Austin L; Rossi G; Fortina P; Yang H; Cristofanilli M
Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27706044
[TBL] [Abstract][Full Text] [Related]
7. Identification and Morphological Characterization of Features of Circulating Cancer-Associated Macrophage-like Cells (CAMLs) in Endometrial Cancers.
Sulaiman R; De P; Aske JC; Lin X; Dale A; Vaselaar E; Ageton C; Gaster K; Espaillat LR; Starks D; Dey N
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230499
[TBL] [Abstract][Full Text] [Related]
8. Cytopathological Heterogeneity of Circulating Tumor Cells in Non-metastatic Esophageal Adenocarcinoma.
Kuvendjiska J; Pitman MB; Martini V; Braun C; Grebe K; Timme S; Fichtner-Feigl S; Glatz T; Schmoor C; Guenzle J; Hoeppner J; Kulemann B
Anticancer Res; 2020 Oct; 40(10):5679-5685. PubMed ID: 32988893
[TBL] [Abstract][Full Text] [Related]
9. Circulating Cancer-Associated Macrophage-Like Cells Differentiate Malignant Breast Cancer and Benign Breast Conditions.
Adams DL; Adams DK; Alpaugh RK; Cristofanilli M; Martin SS; Chumsri S; Tang CM; Marks JR
Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1037-42. PubMed ID: 27197300
[TBL] [Abstract][Full Text] [Related]
10. Blood-based biopsies-clinical utility beyond circulating tumor cells.
Tang CM; Zhu P; Li S; Makarova OV; Amstutz PT; Adams DL
Cytometry A; 2018 Dec; 93(12):1246-1250. PubMed ID: 30369050
[TBL] [Abstract][Full Text] [Related]
11. Contacts with Macrophages Promote an Aggressive Nanomechanical Phenotype of Circulating Tumor Cells in Prostate Cancer.
Osmulski PA; Cunsolo A; Chen M; Qian Y; Lin CL; Hung CN; Mahalingam D; Kirma NB; Chen CL; Taverna JA; Liss MA; Thompson IM; Huang TH; Gaczynska ME
Cancer Res; 2021 Aug; 81(15):4110-4123. PubMed ID: 34045187
[TBL] [Abstract][Full Text] [Related]
12. The biology and clinical potential of circulating tumor cells.
Lozar T; Gersak K; Cemazar M; Kuhar CG; Jesenko T
Radiol Oncol; 2019 May; 53(2):131-147. PubMed ID: 31104002
[TBL] [Abstract][Full Text] [Related]
13. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
[TBL] [Abstract][Full Text] [Related]
14. The Isolation and Analysis of Circulating Tumor Cells.
Guo T; Stankiewicz E; Mao X; Lu YJ
Methods Mol Biol; 2019; 2054():115-128. PubMed ID: 31482451
[TBL] [Abstract][Full Text] [Related]
15. Telomere-Associated Changes in Nuclear Architecture of Cancer-Associated Macrophage-like Cells in Liquid Biopsies from Melanoma Patients.
Rangel-Pozzo A; Wechsler J; Groult J; Da Meda L; Lebbe C; Mai S
Biomedicines; 2022 Sep; 10(10):. PubMed ID: 36289653
[TBL] [Abstract][Full Text] [Related]
16. Clinical and biological significance of circulating tumor cells in cancer.
Masuda T; Hayashi N; Iguchi T; Ito S; Eguchi H; Mimori K
Mol Oncol; 2016 Mar; 10(3):408-17. PubMed ID: 26899533
[TBL] [Abstract][Full Text] [Related]
17.
Mastoraki S; Strati A; Tzanikou E; Chimonidou M; Politaki E; Voutsina A; Psyrri A; Georgoulias V; Lianidou E
Clin Cancer Res; 2018 Mar; 24(6):1500-1510. PubMed ID: 29284708
[No Abstract] [Full Text] [Related]
18. Circulating tumor cells: a multifunctional biomarker.
Yap TA; Lorente D; Omlin A; Olmos D; de Bono JS
Clin Cancer Res; 2014 May; 20(10):2553-68. PubMed ID: 24831278
[TBL] [Abstract][Full Text] [Related]
19. Circulating tumor cells as promising novel biomarkers in solid cancers.
Lianidou ES; Strati A; Markou A
Crit Rev Clin Lab Sci; 2014 Jun; 51(3):160-71. PubMed ID: 24641350
[TBL] [Abstract][Full Text] [Related]
20. The Role of CTCs as Tumor Biomarkers.
Lianidou ES; Markou A; Strati A
Adv Exp Med Biol; 2015; 867():341-67. PubMed ID: 26530376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
